Tevogen BioEquity Warrant Exp 14 February 2029 logo

Tevogen BioEquity Warrant Exp 14 February 2029 Share Price (NASDAQ: TVGNW)

$0.06

Last updated on

Check the interactive Tevogen BioEquity Warrant Exp 14 February 2029 Stock chart to analyse performance

Tevogen Bio Holdings Equity Warrant Exp 14 February 2029 Key Stats

Check Tevogen BioEquity Warrant Exp 14 February 2029 key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.06
Open
$0.0579
Today's Volume
$942.0
Revenue TTM
$0.0
EBITDA
$-31.0M
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Tevogen BioEquity Warrant Exp 14 February 2029 Stock including INR - Dollar returns

The Tevogen BioEquity Warrant Exp 14 February 2029 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tevogen BioEquity Warrant Exp 14 February 2029 investment value today

Current value as on today

₹3,05,284

Returns

₹2,05,284

(+205.28%)

Returns from Tevogen BioEquity Warrant Exp 14 February 2029 Stock

₹2,00,000 (+200%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Tevogen BioEquity Warrant Exp 14 February 2029 Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Tevogen BioEquity Warrant Exp 14 February 2029 Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Tevogen BioEquity Warrant Exp 14 February 2029 Stock

Rating
Trend

Tevogen BioEquity Warrant Exp 14 February 2029 Stock Insights

  • Price Movement

    In the last 1 year, TVGNW stock has moved up by 221.7%

Tevogen BioEquity Warrant Exp 14 February 2029 Technicals Summary

Sell

Neutral

Buy

Tevogen BioEquity Warrant Exp 14 February 2029 is currently in a neutral trading position according to technical analysis indicators.

Tevogen Bio Holdings Equity Warrant Exp 14 February 2029 Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tevogen Bio Holdings Equity Warrant Exp 14 February 2029 logo
-1.35%
-10.92%
159.64%
-39.05%
-39.05%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Tevogen Bio Holdings Equity Warrant Exp 14 February 2029

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Organization
Tevogen BioEquity Warrant Exp 14 February 2029
Employees
18
CEO
Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Industry
Miscellaneous

Key Management of Tevogen Bio Holdings Equity Warrant Exp 14 February 2029

NameTitle
Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Co-Founder, CEO & Chairperson
Mr. Kirti Desai CPA
Chief Financial Officer
Dr. Neal Flomenberg M.D.
Chief Scientific Officer and Global R&D Lead
Mr. Stephen Chen M.B.A.
Chief Technical Officer
Mr. Mittul Mehta
Chief Information Officer & Head of Tevogen.ai
Mr. Tapan V. Shah
Head of Investor Relations & Corporate Development
Mr. Sadiq Khan M.B.A.
Chief Commercial Officer & Interim Head of Tevogen Generics
Mr. David E. Banko CPA
Global Head of Government Affairs & Patient Access

Important FAQs about investing in TVGNW Stock from India :

What is Tevogen BioEquity Warrant Exp 14 February 2029 share price today?

Tevogen BioEquity Warrant Exp 14 February 2029 share price today is $0.06 as on at the close of the market. Tevogen BioEquity Warrant Exp 14 February 2029 share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Tevogen BioEquity Warrant Exp 14 February 2029 share?

Tevogen BioEquity Warrant Exp 14 February 2029 share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Tevogen BioEquity Warrant Exp 14 February 2029 stock price today i.e. is closed at $0.06, lower by 59.97% versus the 52 week high.

How to invest in Tevogen BioEquity Warrant Exp 14 February 2029 Stock (TVGNW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tevogen BioEquity Warrant Exp 14 February 2029 on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tevogen BioEquity Warrant Exp 14 February 2029 Shares that will get you 25.0000 shares as per Tevogen BioEquity Warrant Exp 14 February 2029 share price of $0.06 per share as on August 30, 2025 at 1:26 am IST.

What is the minimum amount required to buy Tevogen BioEquity Warrant Exp 14 February 2029 Stock (TVGNW) from India?

Indian investors can start investing in Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tevogen BioEquity Warrant Exp 14 February 2029 stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Tevogen BioEquity Warrant Exp 14 February 2029 share’s latest price of $0.06 as on August 30, 2025 at 1:26 am IST, you will get 166.6667 shares of Tevogen BioEquity Warrant Exp 14 February 2029. Learn more about fractional shares .

What are the returns that Tevogen BioEquity Warrant Exp 14 February 2029 has given to Indian investors in the last 5 years?

Tevogen BioEquity Warrant Exp 14 February 2029 stock has given -39.05% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?